Cite
COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus
MLA
Chiricozzi, Andrea, et al. COVID-19 Occurrence in One Secukinumab-Treated Patient Affected by Hidradenitis Suppurativa and Systemic Lupus Erythematosus. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1355235588&authtype=sso&custid=ns315887.
APA
Chiricozzi, A., Garcovich, S., Malvaso, D., Giovanardi, G., Peris, K., Chiricozzi A. (ORCID:0000-0002-6739-0387), Garcovich S. (ORCID:0000-0001-8967-6688), Malvaso D., & Peris K. (ORCID:0000-0002-5237-0463). (2020). COVID-19 occurrence in one secukinumab-treated patient affected by hidradenitis suppurativa and systemic lupus erythematosus.
Chicago
Chiricozzi, Andrea, Simone Garcovich, Dalma Malvaso, G. Giovanardi, Ketty Peris, Chiricozzi A. (ORCID:0000-0002-6739-0387), Garcovich S. (ORCID:0000-0001-8967-6688), Malvaso D., and Peris K. (ORCID:0000-0002-5237-0463). 2020. “COVID-19 Occurrence in One Secukinumab-Treated Patient Affected by Hidradenitis Suppurativa and Systemic Lupus Erythematosus.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1355235588&authtype=sso&custid=ns315887.